Dual and triple immunotherapies induced changes in the tumor immune microenvironment compared to monotherapy, increasing the number of CD8+ T cells, CD4+ T cells, NK cells, and CD8+ /Treg ratio, while reducing Treg cells at the endpoint. Here, CD4 is linked to neoplasm.